📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Abstract LB131: Association between epigenetic heterogeneity of esophageal adenocarcinoma and response to first-line immunochemotherapy in LUD2015-005 Trial (2023)

First Author: Xie P

Attributed to: Development of a system to simultaneously detect mutations and epigenetic marks funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1538-7445.am2023-lb131

Publication URI: http://dx.doi.org/10.1158/1538-7445.am2023-lb131

Type: Journal Article/Review

Parent Publication: Cancer Research

Issue: 8_Supplement